{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:03:54Z","timestamp":1760295834918,"version":"3.44.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"publisher","award":["2015CB553704"],"award-info":[{"award-number":["2015CB553704"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.molimm.2018.05.013","type":"journal-article","created":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T07:06:19Z","timestamp":1528355179000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["The combination of FK506 and an anti-CD147 mAb exerts potential therapeutic effects on a mouse model of collagen-induced arthritis"],"prefix":"10.1016","volume":"101","author":[{"given":"Jing","family":"Luan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-meng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Nan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2010","series-title":"ABC of Rheumatology","author":"Adebajo","key":"10.1016\/j.molimm.2018.05.013_bib0005"},{"key":"10.1016\/j.molimm.2018.05.013_bib0010","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.biopha.2017.05.055","article-title":"Rheumatoid arthritis: recent advances on its etiology, role of cytokines and pharmacotherapy","volume":"92","author":"Alam","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.molimm.2018.05.013_bib0015","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3109\/s10165-009-0216-7","article-title":"Prediction of DAS28-CRP remission in patients with rheumatoid arthritis treated with tacrolimus at 6 months by baseline variables","volume":"19","author":"Aramaki","year":"2009","journal-title":"Mod. Rheumatol."},{"issue":"2","key":"10.1016\/j.molimm.2018.05.013_bib0020","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1124\/pr.55.2.4","article-title":"Interleukin-10 therapy--review of a new approach","volume":"55","author":"Asadullah","year":"2003","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.molimm.2018.05.013_bib0025","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2147\/OARRR.S131668","article-title":"Recommendations for optimizing methotrexate treatment for patients with rheumatoid arthritis","volume":"9","author":"Bello","year":"2017","journal-title":"Open Access. Rheumatol."},{"issue":"12","key":"10.1016\/j.molimm.2018.05.013_bib0030","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1002\/1529-0131(200012)43:12<2648::AID-ANR4>3.0.CO;2-M","article-title":"Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis","volume":"43","author":"Bendele","year":"2000","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.molimm.2018.05.013_bib0035","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.autrev.2012.07.011","article-title":"Potential roles for CD8 (+) T cells in rheumatoid arthritis","volume":"12","author":"Carvalheiro","year":"2013","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.molimm.2018.05.013_bib0040","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/art.38941","article-title":"CD8+ T cell profiles in patients with rheumatoid arthritis and their relationship to disease activity","volume":"67","author":"Carvalheiro","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.molimm.2018.05.013_bib0045","first-page":"1","article-title":"Experimental animal models for rheumatoid arthritis","author":"Choudhary","year":"2018","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"Suppl. 1","key":"10.1016\/j.molimm.2018.05.013_bib0050","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar2412","article-title":"T cells in rheumatoid arthritis","volume":"10","author":"Cope","year":"2008","journal-title":"Arthritis Res. Ther."},{"issue":"12","key":"10.1016\/j.molimm.2018.05.013_bib0055","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1182\/blood.V97.12.3984","article-title":"Unavailability of CD147 leads to selective erythrocyte trapping in the spleen","volume":"97","author":"Coste","year":"2001","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.molimm.2018.05.013_bib0060","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2165\/00003495-200565070-00005","article-title":"Tacrolimus: in patients with rheumatoid arthritis","volume":"65","author":"Curran","year":"2005","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.molimm.2018.05.013_bib0065","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2567.2008.02877.x","article-title":"Targeting the chemotactic function of CD147 reduces collagen-induced arthritis","volume":"126","author":"Damsker","year":"2009","journal-title":"Immunology"},{"year":"2007","series-title":"Immunological Tolerance: Methods and Protocols","author":"Fairchild","key":"10.1016\/j.molimm.2018.05.013_bib0070"},{"key":"10.1016\/j.molimm.2018.05.013_bib0075","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1146\/annurev.immunol.14.1.397","article-title":"Role of cytokines in rheumatoid arthritis","volume":"14","author":"Feldmann","year":"1996","journal-title":"Annu. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.molimm.2018.05.013_bib0080","first-page":"2332","article-title":"Tacrolimus (FK506) in the treatment of severe, refractory rheumatoid arthritis: initial experience in 12 patients","volume":"26","author":"Gremillion","year":"1999","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.molimm.2018.05.013_bib0085","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.intimp.2016.06.029","article-title":"Therapeutic effect of dioscin on collagen-induced arthritis through reduction of Th1\/Th2","volume":"39","author":"Guo","year":"2016","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.molimm.2018.05.013_bib0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1189\/jlb.3RU0215-045R","article-title":"The role of EMMPRIN in T cell biology and immunological diseases","volume":"98","author":"Hahn","year":"2015","journal-title":"J. Leukoc. Biol."},{"issue":"11","key":"10.1016\/j.molimm.2018.05.013_bib0095","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1136\/ard.2007.076430","article-title":"Utility of animal models for identification of potential therapeutics for rheumatoid arthritis","volume":"67","author":"Hegen","year":"2008","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.molimm.2018.05.013_bib0100","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1699-0463.1989.tb00446.x","article-title":"Collagen induced arthritis as an experimental model for rheumatoid arthritis. Immunogenetics, pathogenesis and autoimmunity","volume":"97","author":"Holmdahl","year":"1989","journal-title":"APMIS"},{"issue":"4","key":"10.1016\/j.molimm.2018.05.013_bib0105","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nprot.2008.19","article-title":"Protocol for the induction of arthritis in C57BL\/6 mice","volume":"3","author":"Inglis","year":"2008","journal-title":"Nat. Protoc."},{"issue":"7","key":"10.1016\/j.molimm.2018.05.013_bib0110","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/rheumatology\/kep099","article-title":"Inhibitory effect of CD147\/HAb18 monoclonal antibody on cartilage erosion and synovitis in the SCID mouse model for rheumatoid arthritis","volume":"48","author":"Jia","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.molimm.2018.05.013_bib0115","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/14397595.2016.1181315","article-title":"The efficacy and safety of additional administration of tacrolimus in patients with rheumatoid arthritis who showed an inadequate response to tocilizumab","volume":"27","author":"Kaneshiro","year":"2017","journal-title":"Mod. Rheumatol."},{"issue":"11","key":"10.1016\/j.molimm.2018.05.013_bib0120","first-page":"2153","article-title":"Comparison of tacrolimus and mizoribine in a randomized, double-blind controlled study in patients with rheumatoid arthritis","volume":"33","author":"Kawai","year":"2006","journal-title":"J. Rheumatol."},{"issue":"3","key":"10.1016\/j.molimm.2018.05.013_bib0125","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10875-005-4092-4","article-title":"mRNA quantification of T-bet, GATA-3, IFN-gamma, and IL-4 shows a defective Th1 immune response in the peripheral blood from rheumatoid arthritis patients: link with disease activity","volume":"25","author":"Kawashima","year":"2005","journal-title":"J. Clin. Immunol."},{"issue":"14","key":"10.1016\/j.molimm.2018.05.013_bib0130","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1093\/ajhp\/52.14.1521","article-title":"Tacrolimus: a new immunosuppressive agent","volume":"52","author":"Kelly","year":"1995","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"3","key":"10.1016\/j.molimm.2018.05.013_bib0135","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.4049\/jimmunol.164.3.1576","article-title":"Viral IL-10 and soluble TNF receptor act synergistically to inhibit collagen-induced arthritis following adenovirus-mediated gene transfer","volume":"164","author":"Kim","year":"2000","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.molimm.2018.05.013_bib0140","doi-asserted-by":"crossref","first-page":"6440","DOI":"10.4049\/jimmunol.174.10.6440","article-title":"Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis","volume":"174","author":"Kim","year":"2005","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.molimm.2018.05.013_bib0145","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s12253-013-9687-0","article-title":"Alterations in both the activatory and inhibitory potential of peripheral blood CD4+ T cells in rheumatoid arthritis patients correlate with disease progression","volume":"20","author":"Kosmaczewska","year":"2014","journal-title":"Pathol. Oncol. Res."},{"issue":"4","key":"10.1016\/j.molimm.2018.05.013_bib0150","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/03009740903501642","article-title":"Tacrolimus for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials","volume":"39","author":"Lee","year":"2010","journal-title":"Scand. J. Rheumatol."},{"issue":"12","key":"10.1016\/j.molimm.2018.05.013_bib0155","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1172\/JCI7739","article-title":"IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion","volume":"105","author":"Lubberts","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.molimm.2018.05.013_bib0160","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/CMR.9.4.532","article-title":"Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases","volume":"9","author":"Lucey","year":"1996","journal-title":"Clin. Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.molimm.2018.05.013_bib0165","doi-asserted-by":"crossref","first-page":"R14","DOI":"10.1186\/ar2365","article-title":"Cartilage preservation by inhibition of Janus kinase 3 in two rodent models of rheumatoid arthritis","volume":"10","author":"Milici","year":"2008","journal-title":"Arthritis Res. Ther."},{"issue":"12","key":"10.1016\/j.molimm.2018.05.013_bib0170","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/art.1780401203","article-title":"Th1\/Th2 cytokine balance in arthritis","volume":"40","author":"Miossec","year":"1997","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.molimm.2018.05.013_bib0175","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00296-009-0845-3","article-title":"Adding low dose tacrolimus in rheumatoid arthritis patients with an inadequate response to tumor necrosis factor inhibitor therapies","volume":"29","author":"Naniwa","year":"2009","journal-title":"Rheumatol. Int"},{"key":"10.1016\/j.molimm.2018.05.013_bib0180","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-065X.2008.00635.x","article-title":"Strategies for use of IL-10 or its antagonists in human disease","volume":"223","author":"O\u2019Garra","year":"2008","journal-title":"Immunol. Rev."},{"year":"2018","series-title":"Drug Survival and the Associated Predictors in South Korean Patients with Rheumatoid Arthritis Receiving Tacrolimus","author":"Park","key":"10.1016\/j.molimm.2018.05.013_bib0185"},{"issue":"2","key":"10.1016\/j.molimm.2018.05.013_bib0190","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1582-4934.2007.00022.x","article-title":"Roles of CD147 on T lymphocytes activation and MMP-9 secretion in systemic lupus erythematosus","volume":"11","author":"Pistol","year":"2007","journal-title":"J. Cell Mol. Med."},{"issue":"4","key":"10.1016\/j.molimm.2018.05.013_bib0195","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00054725-199911000-00009","article-title":"Th1\/Th2 cells","volume":"5","author":"Romagnani","year":"1999","journal-title":"Inflamm. Bowel Dis."},{"issue":"4","key":"10.1016\/j.molimm.2018.05.013_bib0200","first-page":"209","article-title":"IL-4 can inhibit IL-17 production in collagen induced arthritis","volume":"8","author":"Sandoghchian","year":"2011","journal-title":"Iran J. Immunol."},{"issue":"5","key":"10.1016\/j.molimm.2018.05.013_bib0205","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1053\/berh.2001.0187","article-title":"The balance of Th1\/Th2 cytokines in rheumatoid arthritis","volume":"15","author":"Schulze-Koops","year":"2001","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"3","key":"10.1016\/j.molimm.2018.05.013_bib0210","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/annrheumdis-2013-204573","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update","volume":"73","author":"Smolen","year":"2014","journal-title":"Ann. Rheum Dis."},{"issue":"10055","key":"10.1016\/j.molimm.2018.05.013_bib0215","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.molimm.2018.05.013_bib0220","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0889-857X(03)00073-5","article-title":"Gene therapy for rheumatoid arthritis. Lessons from animal models, including studies on interleukin-4, interleukin-10, and interleukin-1 receptor antagonist as potential disease modulators","volume":"28","author":"van de Loo","year":"2002","journal-title":"Rheum. Dis. Clin North. Am."},{"issue":"4","key":"10.1016\/j.molimm.2018.05.013_bib0225","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1582-4934.2010.01084.x","article-title":"Expression of CD147 (EMMPRIN) on neutrophils in rheumatoid arthritis enhances chemotaxis, matrix metalloproteinase production and invasiveness of synoviocytes","volume":"15","author":"Wang","year":"2011","journal-title":"J. Cell Mol. Med."},{"issue":"2","key":"10.1016\/j.molimm.2018.05.013_bib0230","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1160\/TH04-08-0536","article-title":"Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression","volume":"93","author":"Yan","year":"2005","journal-title":"Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.molimm.2018.05.013_bib0235","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1002\/art.11363","article-title":"Efficacy and safety of tacrolimus in patients with rheumatoid arthritis: a double-blind trial","volume":"48","author":"Yocum","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.molimm.2018.05.013_bib0240","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/rheumatology\/keh155","article-title":"Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience","volume":"43","author":"Yocum","year":"2004","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.molimm.2018.05.013_bib0245","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00296-008-0694-5","article-title":"Efficacy of tacrolimus in infliximab-refractory progressive rheumatoid arthritis","volume":"29","author":"Yokota","year":"2009","journal-title":"Rheumatol. Int."},{"issue":"3","key":"10.1016\/j.molimm.2018.05.013_bib0250","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10875-011-9508-8","article-title":"Trichostatin differentially regulates Th1 and Th2 responses and alleviates rheumatoid arthritis in mice","volume":"31","author":"Zhou","year":"2011","journal-title":"J. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.molimm.2018.05.013_bib0255","doi-asserted-by":"crossref","first-page":"R44","DOI":"10.1186\/ar1899","article-title":"CD147 overexpression on synoviocytes in rheumatoid arthritis enhances matrix metalloproteinase production and invasiveness of synoviocytes","volume":"8","author":"Zhu","year":"2006","journal-title":"Arthritis Res. Ther."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589018301585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589018301585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:30:59Z","timestamp":1758979859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589018301585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":51,"alternative-id":["S0161589018301585"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2018.05.013","relation":{},"ISSN":["0161-5890"],"issn-type":[{"type":"print","value":"0161-5890"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The combination of FK506 and an anti-CD147 mAb exerts potential therapeutic effects on a mouse model of collagen-induced arthritis","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2018.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}